SCF ubiquitin ligase-targeted therapies

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature reviews. Drug discovery

• Publication date

  2014-11-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrd4432PMID 25394868PMCID PMC4410837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma

  2014cited by this paper
• New insights into ubiquitin E3 ligase mechanism

  2014cited by this paper
• Roles of F-box proteins in cancer

  2014cited by this paper
• Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer.

  2014cited by this paper
• Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.

  2014cited by this paper
• Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer

  2014cited by this paper
• Discovery and saturation analysis of cancer genes across 21 tumor types

  2014cited by this paper
• Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system.

  2014cited by this paper
• Macrocerebellum, epilepsy, intellectual disability, and gut malrotation in a child with a 16q24.1–q24.2 contiguous gene deletion

  2014cited by this paper
• Nature Biotechnology's academic spinouts of 2013

  2014cited by this paper
• Targeting nuclear kinases in cancer: development of cell cycle kinase inhibitors.

  2014cited by this paper
• Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

  2014cited by this paper
• Overactivated neddylation pathway as a therapeutic target in lung cancer.

  2014cited by this paper
• Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells

  2014cited by this paper
• A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.

  2014cited by this paper
• Truncation of the E3 ubiquitin ligase component FBXO31 causes non-syndromic autosomal recessive intellectual disability in a Pakistani family

  2014cited by this paper
• Regulation of proteasome activity in health and disease.

  2014cited by this paper
• Yeast Augmented Network Analysis (YANA): a new systems approach to identify therapeutic targets for human genetic diseases

  2014cited by this paper
• New hepatitis C therapies: the toolbox, strategies, and challenges.

  2014cited by this paper
• The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins

  2014cited by this paper
• Antiviral treatment of hepatitis C

  2014cited by this paper
• POSTER PRESENTATION Open Access

  2013cited by this paper
• FBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascade

  2013cited by this paper
• SCFFbxl3 Ubiquitin Ligase Targets Cryptochromes at Their Cofactor Pocket

  2013cited by this paper
• Linear ubiquitination: a newly discovered regulator of cell signalling.

  2013cited by this paper
• Targeting F Box Protein Fbxo3 To Control Cytokine-Driven Inflammation

  2013cited by this paper
• The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.

  2013cited by this paper
• Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence.

  2013cited by this paper
• Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression.

  2013cited by this paper
• CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration.

  2013cited by this paper
• Building and remodelling Cullin–RING E3 ubiquitin ligases

  2013cited by this paper
• Crystal structure of mammalian cryptochrome in complex with a small molecule competitor of its ubiquitin ligase

  2013cited by this paper
• Regulation of the CRL4(Cdt2) ubiquitin ligase and cell-cycle exit by the SCF(Fbxo11) ubiquitin ligase.

  2013cited by this paper
• Mechanisms and function of substrate recruitment by F-box proteins

  2013cited by this paper
• Ubiquitin E3 Ligase CRL4CDT2/DCAF2 as a Potential Chemotherapeutic Target for Ovarian Surface Epithelial Cancer*

  2013cited by this paper
• Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy.

  2013cited by this paper
• GS-1101: A Delta-Specific PI3K Inhibitor in Chronic Lymphocytic Leukemia

  2013cited by this paper
• Skp-cullin-F box E3 ligase component FBXL2 ubiquitinates Aurora B to inhibit tumorigenesis

  2013cited by this paper
• Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression.

  2013cited by this paper
• Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.

  2013cited by this paper
• WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells

  2013cited by this paper
• A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation

  2013cited by this paper
• Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924.

  2013cited by this paper
• Structure–Activity Relationship Study Reveals ML240 and ML241 as Potent and Selective Inhibitors of p97 ATPase

  2013cited by this paper
• Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells

  2013cited by this paper
• Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death.

  2013cited by this paper
• Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance.

  2013cited by this paper
• E2 enzyme inhibition by stabilization of a low affinity interface with ubiquitin

  2013cited by this paper
• P97/CDC-48: proteostasis control in tumor cell biology.

  2013cited by this paper
• HIV-1 Vpu Interference with Innate Cell-mediated Immune Mechanisms

  2012cited by this paper
• A gatekeeper residue for NEDD8-activating enzyme inhibition by MLN4924.

  2012cited by this paper
• Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924.

  2012cited by this paper
• A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.

  2012cited by this paper
• Identification of Small Molecule Activators of Cryptochrome

  2012cited by this paper
• FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas

  2012cited by this paper
• Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47.

  2012cited by this paper
• NEDD8 links Cullin–Ring ubiquitin Ligase function to the p97 pathway

  2012cited by this paper
• More Than a Protease

  2012cited by this paper
• Initial testing of the investigational NEDD8‐activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program

  2012cited by this paper
• Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma

  2012cited by this paper
• HECT and RING finger families of E3 ubiquitin ligases at a glance

  2012cited by this paper
• Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

  2012cited by this paper
• Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

  2012cited by this paper
• Signal-induced disassembly of the SCF ubiquitin ligase complex by Cdc48/p97.

  2012cited by this paper
• The ubiquitin code.

  2012cited by this paper
• Erioflorin Stabilizes the Tumor Suppressor Pdcd4 by Inhibiting Its Interaction with the E3-ligase β-TrCP1

  2012cited by this paper
• MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL.

  2012cited by this paper
• F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation.

  2012cited by this paper
• Specific small molecule inhibitors of Skp2-mediated p27 degradation.

  2012cited by this paper
• Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor.

  2012cited by this paper
• 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma

  2012cited by this paper
• A noncanonical cysteine protease USP1 is activated through active site modulation by USP1-associated factor 1.

  2012cited by this paper
• Serine phosphorylation is critical for the activation of ubiquitin-specific protease 1 and its interaction with WD40-repeat protein UAF1.

  2012cited by this paper
• Ubiquitin-based anticancer therapy: Carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors☆

  2012cited by this paper
• A High‐Throughput Screening Method for Identification of Inhibitors of the Deubiquitinating Enzyme USP14

  2012cited by this paper
• Calmodulin Antagonizes a Calcium-Activated SCF Ubiquitin E3 Ligase Subunit, FBXL2, To Regulate Surfactant Homeostasis

  2011cited by this paper
• PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic.

  2011cited by this paper
• Frequent pathway mutations of splicing machinery in myelodysplasia

  2011cited by this paper
• F box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest

  2011cited by this paper
• Mechanistic Studies of Substrate-assisted Inhibition of Ubiquitin-activating Enzyme by Adenosine Sulfamate Analogues

  2011cited by this paper
• Novel proteasome inhibitors to overcome bortezomib resistance.

  2011cited by this paper
• The Multifaceted Roles of USP7: New Therapeutic Opportunities

  2011cited by this paper
• An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme.

  2011cited by this paper
• Teratogenic effects of thalidomide: molecular mechanisms

  2011cited by this paper
• The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

  2011cited by this paper
• Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase.

  2011cited by this paper
• MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells.

  2011cited by this paper
• Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells

  2011cited by this paper
• Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells.

  2011cited by this paper
• Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)

  2011cited by this paper
• NEDD8 pathways in cancer, Sine Quibus Non.

  2011cited by this paper
• Oncogenic activation of NF-kappaB.

  2010cited by this paper
• MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma.

  2010cited by this paper
• Diverse somatic mutation patterns and pathway alterations in human cancers.

  2010cited by this paper
• Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant.

  2010cited by this paper
• Oncogenic Activation of NF- k B

  2010cited by this paper
• Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase.

  2010cited by this paper
• The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation

  2010cited by this paper
• New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

  2010cited by this paper
• An allosteric inhibitor of substrate recognition by the SCFCdc4 ubiquitin ligase

  2010cited by this paper

• Guaianolide dimer KGA-1002 targets GRP94 and triggers unfolded protein response-associated degradation of SKP2/AKT axis as a novel antihepatoma agent.

  2026cites this paper
• The negative regulated immune mechanism of Skp1-Cullin1-F-box (SCF) E3 ubiquitin ligase-mediated HOS15-dependent responses in banana

  2025cites this paper
• Identification of a ubiquitin-binding domain protein, CD2AP, in predicting the prognosis and treatment of lung adenocarcinoma

  2025cites this paper
• VOPP1, a Determinant of the Sensitivity of Non-Small Cell Lung Cancer Cells to NAE Inhibitors.

  2025cites this paper
• Therapeutic potential of allosteric HECT E3 ligase inhibition

  2025cites this paper
• Legionella pneumophila Effector Protein LegU1 Mediates the Ubiquitination of Endoplasmic Reticulum Chaperone BiP

  2025cites this paper
• Challenges and opportunities for the diverse substrates of SPOP E3 ubiquitin ligase in cancer

  2025cites this paper
• PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer

  2025cites this paper
• Cdk1 and PP2A constitute a molecular switch controlling orderly degradation of atypical E2Fs

  2025cites this paper
• Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?

  2025cites this paper
• The FBXO45–GEF-H1 Axis Controls Germinal Center Formation and B-cell Lymphomagenesis

  2025cites this paper
• [Filamins, T helper 2 lymphocytes and asthma : A matter of balance].

  2025cites this paper
• Adult B-Cell Acute Lymphoblastic Leukaemia Antigens and Enriched Pathways Identify New Targets for Therapy

  2025cites this paper
• Spatiotemporally controlled ferritin-targeting PROTAC nanoplatform for visualized manipulation of endogenous “Iron pool” in pancreatic cancer therapy

  2025cites this paper
• Distinct outcomes from targeted perturbations of the multi-subunit SCFSkp2 E3 ubiquitin ligase in blocking Trp53/Rb1-null prostate tumorigenesis

  2025cites this paper
• Porphyrins and Their Derivatives in Cancer Therapy: Current Advances, Mechanistic Insights, and Prospective Directions.

  2025cites this paper
• Ubiquitin degradation of the Ribonuclease H2 subunit B Rnh2B regulates the virulence of Cryptococcus neoformans

  2025cites this paper
• Application of mass spectrometry for the advancement of PROTACs.

  2025cites this paper
• FBXO22 Suppresses Oxidative Stress-Induced ASK1 Activation and Cell Death via Ubiquitination-Dependent Degradation of TRIM48

  2025influential citation
• The structure and function of FBXW5 in human diseases

  2025cites this paper
• Methodological comparison between salivary and plasma inflammatory biomarkers in third molar surgery patients

  2025cites this paper
• Ubiquitin and SUMO pathways in DNA replication and replication-coupled repair

  2025cites this paper
• FBXO2 promotes hepatocellular carcinoma progression and sorafenib resistance by targeting USP49 for proteasomal degradation

  2025cites this paper
• Phosphodegrons in Health and Disease: From Cellular Homeostasis to Therapeutic Potential

  2025cites this paper
• GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation

  2025cites this paper
• F-box proteins and gastric cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects

  2024cites this paper
• Unraveling role of ubiquitination in drug resistance of gynecological cancer.

  2024cites this paper
• DCAF15 control of cohesin dynamics sustains acute myeloid leukemia

  2024cites this paper
• Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease

  2024cites this paper
• E3 Ubiquitin Ligases and Their Therapeutic Applications in Cancers: Narrative Review

  2024cites this paper
• Identification of Skp1 as a target of mercury sulfide for neuroprotection.

  2024cites this paper
• SCFFBXW5-mediated degradation of AQP3 suppresses autophagic cell death through the PDPK1-AKT-MTOR axis in hepatocellular carcinoma cells

  2024cites this paper
• Mercuric sulfide nanoparticles suppress the neurobehavioral functions of Caenorhabditis elegans through a Skp1-dependent mechanism.

  2024cites this paper
• FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression

  2024cites this paper
• E3 ligase FBXO22 is not significant for spermatogenesis and male fertility in mice.

  2024cites this paper
• FBXO2 promotes the progression of papillary thyroid carcinoma through the p53 pathway

  2024cites this paper
• FBXO38 is dispensable for PD-1 regulation

  2024cites this paper
• Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia

  2024cites this paper
• Ubiquitin ligase RNF20 coordinates sequential adipose thermogenesis with brown and beige fat-specific substrates

  2024cites this paper
• A cell-permeable Ub-Dha probe for profiling E1-E2-E3 enzymes in live cells.

  2024cites this paper
• Cadmium binding by the F-box domain induces p97-mediated SCF complex disassembly to activate stress response programs

  2024cites this paper
• Ubiquitin proteasome system in cardiac fibrosis

  2024cites this paper
• MetaDegron: multimodal feature-integrated protein language model for predicting E3 ligase targeted degrons

  2024cites this paper
• Role for the F-box Proteins in Heart Diseases.

  2024cites this paper
• A patent review of SCF E3 ligases inhibitors for cancer：Structural design, pharmacological activities and structure-activity relationship.

  2024cites this paper
• Fine-tuning levels of filamins a and b as a specific mechanism sustaining Th2 lymphocyte functions

  2024cites this paper
• Therapeutic Strategies for RB1-Deficient Cancers: Intersecting Gene Regulation and Targeted Therapy

  2024cites this paper
• A CRISPR activation screen identifies FBXO22 supporting targeted protein degradation

  2024cites this paper
• Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches

  2024cites this paper
• ISGylation of NF-κBp65 by SCFFBXL19 E3 Ligase Diminishes Endothelial Inflammation

  2023cites this paper
• BC-1215 inhibits ATP-induced IL-1β secretion via the FBXL2-mediated ubiquitination and degradation of not only NLRP3, but also pro-IL-1β in LPS-primed THP-1 cells.

  2023cites this paper
• Addressing the Binding Mechanism of the Meprin and TRAF-C Homology Domain of the Speckle-Type POZ Protein Using Protein Engineering

  2023cites this paper
• A noncanonical function of SKP1 regulates the switch between autophagy and unconventional secretion

  2023cites this paper
• The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer

  2023cites this paper
• Ginsenoside 20(S)-Rg3 reduces KIF20A expression and promotes CDC25A proteasomal degradation in epithelial ovarian cancer

  2023cites this paper
• NLRP6 potentiates PI3K/AKT signalling by promoting autophagic degradation of p85α to drive tumorigenesis

  2023cites this paper
• Discovery of Novel 1,3-Diphenylpyrazine Derivatives as Potent S-Phase Kinase-Associated Protein 2 (Skp2) Inhibitors for the Treatment of Cancer.

  2023cites this paper
• Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy

  2023cites this paper
• FBXW2 suppresses breast tumorigenesis by targeting AKT-Moesin-SKP2 axis

  2023cites this paper
• TRAF6 Promotes PRMT5 Activity in a Ubiquitination-Dependent Manner

  2023cites this paper
• ALS-linked CCNF variant disrupts motor neuron ubiquitin homeostasis

  2023cites this paper
• A review of deubiquitinases and thier roles in tumorigenesis and development

  2023cites this paper
• A CRISPR activation screen identifies FBXO22 as an E3 ligase supporting targeted protein degradation

  2023cites this paper
• FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

  2023cites this paper
• Biophysical Characterization of the Binding Mechanism between the MATH Domain of SPOP and Its Physiological Partners

  2023cites this paper
• Acyl azide modification of the ubiquitin C-terminus enables DUB capture.

  2023cites this paper
• Ubiquitination of NKCC2 by the cullin-RING E3 ubiquitin ligase family in the thick ascending limb of the loop of Henle

  2023cites this paper
• The E3 ubiquitin ligases regulate inflammation in cardiovascular diseases.

  2023cites this paper
• Osteocytes directly regulate osteolysis via MYD88 signaling in bacterial bone infection

  2022cites this paper
• Ubiquitin proteasome system in immune regulation and therapeutics.

  2022cites this paper
• FBXL6 depletion restrains clear cell renal cell carcinoma progression

  2022cites this paper
• Checkpoint Nano‐PROTACs for Activatable Cancer Photo‐Immunotherapy

  2022cites this paper
• USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma

  2022cites this paper
• SPOP in Cancer: Phenomena, Mechanisms and Its Role in Therapeutic Implications

  2022cites this paper
• SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy

  2022cites this paper
• FBXO38 Ubiquitin Ligase Controls Centromere Integrity via ZXDA/B Stability

  2022cites this paper
• Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition

  2022cites this paper
• Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy

  2022cites this paper
• The role of Fbxo5 in the development of human malignant tumors.

  2022cites this paper
• Functional characterization of FBXL7 as a novel player in human cancers

  2022cites this paper
• PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

  2022cites this paper
• Aberrant SKP1 Expression: Diverse Mechanisms Impacting Genome and Chromosome Stability

  2022cites this paper
• Cigarette smoking is a secondary cause of folliculin loss

  2022cites this paper
• A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy

  2022cites this paper
• Engineering POLYTAC Nanoparticles for Bioorthogonal Click Reaction-Enforced Protein Degradation and Breast Cancer Therapy

  2022cites this paper
• Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy.

  2022cites this paper
• The Emerging Role of PRMT6 in Cancer

  2022cites this paper
• The DUB Club: Deubiquitinating Enzymes and Neurodevelopmental Disorders.

  2022cites this paper
• FBXO2 targets glycosylated SUN2 for ubiquitination and degradation to promote ovarian cancer development

  2022cites this paper
• Diverse Roles of F-BoxProtein3 in Regulation of Various Cellular Functions

  2022cites this paper
• Sensing and Signaling of Methionine Metabolism

  2021cites this paper
• Extracellular matrix stiffness regulates degradation of the Hippo kinase MST2 via SCF βTrCP

  2021cites this paper
• Variant recurrence confirms the existence of a FBXO31‐related spastic‐dystonic cerebral palsy syndrome

  2021cites this paper
• GASC1 promotes hepatocellular carcinoma progression by inhibiting the degradation of ROCK2

  2021cites this paper
• Melatonin supplementation in the culture medium rescues impaired glucose metabolism in IVF mice offspring

  2021cites this paper
• Identification and optimization of molecular glue compounds that inhibit a noncovalent E2 enzyme–ubiquitin complex

  2021cites this paper
• FBXL6 degrades phosphorylated p53 to promote tumor growth

  2021cites this paper
• E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential

  2021cites this paper
• Macrocyclic DNA-encoded chemical libraries: a historical perspective

  2021cites this paper
• Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways

  2021cites this paper